InPress Technologies closes trial of postpartum hemorrhage device

InPress Technologies successfully closes a 1st-in-human trial of its disposable device for treating postpartum hemorrhage.

It took less than 9 months for InPress Technologies to fund and successfully conclude a 1st-in-human trial of its disposable device for treating postpartum hemorrhage, co-founder & CEO Jessie Becker said last week.

InPress Technologies

News Well, Clinical Trials, Obstetrics

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1G3XQRO